Warning
Heritage Pharmaceuticals Inc Recalls CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0768-2026Drug / Pharmaceutical
Heritage Pharmaceuticals Inc Recalls CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION
Heritage Pharmaceuticals Inc · Class II — Moderate Risk
Product Description
CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
Reason for Recall
Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the U.S
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Heritage Pharmaceuticals Inc has recalled a pharmaceutical product that the FDA classified as Class II. The recall was initiated on July 30, 2026. Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.